Literature DB >> 2425458

Intratracheal versus intravenous administration of bleomycin in mice: acute effects.

R C Lindenschmidt, A F Tryka, G A Godfrey, E L Frome, H Witschi.   

Abstract

We examined whether intratracheal instillation (IT) of bleomycin would produce similar or dissimilar lesions when compared to lung damage following intravenous (iv) injection of the drug. BALB/c mice were treated with either 4 U/kg IT or 100 U iv bleomycin and killed at intervals up to 21 days after treatment. Cell proliferation, histopathology, lung lavage, and hydroxyproline content were examined. There was a biphasic response in the cell proliferation in the IT-treated mice, while the iv-treated mice showed a single delayed peak in proliferation. The histopathologic features of interstitial pneumonitis, elevation of lung lavage enzyme activities, and lung hydroxyproline content were qualitatively similar between the two routes of administration, although the IT mice response was always greater in magnitude. Differences exist between the lung reaction to these two routes of administration, but these differences reflect nonspecific inflammatory response and magnitude of initial injury. We conclude that the response to bleomycin administered IT is basically similar to the changes produced by intravenous injection of the drug.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425458     DOI: 10.1016/0041-008x(86)90388-1

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Alveolar surfactant protein D content modulates bleomycin-induced lung injury.

Authors:  John Casey; Jennifer Kaplan; Elena N Atochina-Vasserman; Andrew J Gow; Helchem Kadire; Yaniv Tomer; James H Fisher; Samuel Hawgood; Rashmin C Savani; Michael F Beers
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

2.  Time course of bleomycin-induced lung fibrosis.

Authors:  G Izbicki; M J Segel; T G Christensen; M W Conner; R Breuer
Journal:  Int J Exp Pathol       Date:  2002-06       Impact factor: 1.925

3.  Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.

Authors:  E N Unemori; L B Pickford; A L Salles; C E Piercy; B H Grove; M E Erikson; E P Amento
Journal:  J Clin Invest       Date:  1996-12-15       Impact factor: 14.808

4.  Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.

Authors:  M A Olman; N Mackman; C L Gladson; K M Moser; D J Loskutoff
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  Fatty acid nitroalkenes inhibit the inflammatory response to bleomycin-mediated lung injury.

Authors:  Melissa L Wilkinson; Elena Abramova; Changjiang Guo; James G Gow; Alexa Murray; Adolf Koudelka; Veronika Cechova; Bruce A Freeman; Andrew J Gow
Journal:  Toxicol Appl Pharmacol       Date:  2020-09-12       Impact factor: 4.219

6.  Intratracheal Administration of Acyl Coenzyme A Acyltransferase-1 Inhibitor K-604 Reduces Pulmonary Inflammation Following Bleomycin-Induced Lung Injury.

Authors:  Emily R Stevenson; Melissa L Wilkinson; Elena Abramova; Changjiang Guo; Andrew J Gow
Journal:  J Pharmacol Exp Ther       Date:  2022-08-15       Impact factor: 4.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.